Skip to main content

Leaders of the Federation of State Medical Boards share their perspectives on the emerging issue of whether artificial intelligence should be licensed to practice medicine. They explore the implications and challenges involved in governing AI within medical practice.

Insights from the Federation of State Medical Boards on AI Licensing in Healthcare

Medical educators encourage proficiency with AI scribes for future doctors but express concern about the impact of relying on AI for clinical documentation on educational outcomes.

AI Scribes in Medical Training: Helpful Assistants or Hindrances to Learning?

Former VA Secretary David Shulkin highlights the powerful alliance of HHS, the VA, and the DOD as a uniquely American innovation hub that competitors like China find hard to match, emphasizing its potential to drive biotech advancement.

How the VA Can Boost America’s Edge in the Biotechnology Race Against China

Congress is rushing to pass several important health care bills before its August recess, focusing on issues like price transparency and the streamlining of prior authorization processes.

Final Push: Congress Advances Key Health Care Legislation Ahead of Recess

Peter Pronovost, Justin Norden, and Kedar Mate emphasize that senior leaders must take daily responsibility for AI governance in hospitals rather than leaving it to a technology committee that meets infrequently.

Opinion: Who's Ensuring Proper Oversight of AI in Hospitals?

CMS aims to create a standardized payment model for clinical software and AI that emphasizes their effectiveness in improving patient outcomes.

CMS Plans New Payment Framework for Clinical Software and AI

Prediction markets, long established in sports, politics, and entertainment, are now making their way into the biopharma sector. This innovation aims to apply market-based forecasting to clinical trials and FDA approval outcomes, potentially transforming how drug development risks and timelines are assessed.

Kalshi Targets Biopharma with Prediction Markets for Clinical Trials and FDA Approvals

The Trump administration initiated a pilot program using artificial intelligence to streamline Medicare approvals for certain medical services, but efforts to end this test have been blocked by the GOP.

GOP Opposes Ending Medicare AI Prior Authorization Pilot

Deepfakes are rapidly eroding the trust essential for digital healthcare services such as telehealth and patient portals. These convincing but fake representations of medical professionals threaten the integrity and reliability that patients depend on when seeking remote care and accessing personal health information online.

Opinion: When Your Doctor's Digital Double Isn't Really Your Doctor

AI is transforming the field of medicine. The physicians responsible for patient outcomes need to be at the forefront of how AI is integrated into healthcare, ensuring it benefits patient care effectively and ethically—as emphasized by Afnan R. Tariq and Ami Bhatt.

Rethinking AI Licensure: Physicians Must Guide Its Role in Medicine